Stock Events

Stock Events

Premier Biomedical 

$0
1
+$0+20% Thursday 19:53

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
11,226,034
Avg. Volume
-
Mkt Cap
779,988
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

15MayExpected
Q2 2018
Q3 2018
Q1 2019
Q2 2019
Q3 2019
Q3 2019
Q1 2020
-0.14
-0.09
-0.05
-0
Expected EPS
N/A
Actual EPS
-0.0004

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-198,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIEI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for many of the same diseases that Premier Biomedical targets, making them direct competitors in the pharmaceutical and biotech industry.
Pfizer
PFE
Mkt Cap156.77B
Pfizer Inc. operates in the pharmaceutical and biotechnology industry, developing and marketing drugs and vaccines for diseases that overlap with Premier Biomedical's research areas, positioning them as competitors.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson is a comprehensive healthcare company that engages in the research and development of pharmaceuticals and biotechnological treatments, competing in similar therapeutic areas as Premier Biomedical.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie Inc. focuses on pharmaceuticals, including therapies for conditions that Premier Biomedical is also targeting, making them competitors in the biopharmaceutical sector.
AMGEN
AMGN
Mkt Cap191.53B
Amgen Inc. is a biopharmaceutical company that develops innovative therapies, including for diseases that Premier Biomedical is also interested in, making them direct competitors in the biotech industry.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol-Myers Squibb Company is involved in the discovery, development, and marketing of drugs in areas that overlap with Premier Biomedical's interests, making them competitors in the pharmaceutical industry.
Gilead Sciences
GILD
Mkt Cap170.84B
Gilead Sciences, Inc. focuses on the development and marketing of drugs in areas such as infectious diseases, a field that Premier Biomedical may also be involved in, positioning them as competitors.
Novartis
NVS
Mkt Cap293.34B
Novartis AG is a global healthcare company that researches and develops drugs in many of the same therapeutic areas as Premier Biomedical, making them direct competitors in the pharmaceutical industry.
Roche
RHHBY
Mkt Cap330.22B
Roche Holding AG engages in the research and development of pharmaceuticals and diagnostics, competing in similar fields as Premier Biomedical, especially in oncology and immunology.
Sanofi
SNY
Mkt Cap115.14B
Sanofi is a global life sciences company that focuses on healthcare solutions, including pharmaceuticals and vaccines, in areas that overlap with Premier Biomedical's research, making them competitors.

About

Premier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. It focuses on the development and distribution of hemp oil based topical pain relief products. The company was founded by Mitchell S. Felder on May 10, 2010 and is headquartered in Knoxville, TN.
Show more...
CEO
Mr. David Caplan
Employees
4
Country
United States
ISIN
US74048K2033

Listings

OTC Link
US
BIEI

0 Comments

Share your thoughts

FAQ

What is Premier Biomedical stock price today?▼
The current price of BIEI is $0 USD — it has increased by +20% in the past 24 hours. Watch Premier Biomedical stock price performance more closely on the chart.
What is Premier Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Premier Biomedical stocks are traded under the ticker BIEI.
Is Premier Biomedical stock price growing?▼
BIEI stock has risen by +50% compared to the previous week, the month change is a +50% rise, over the last year Premier Biomedical has showed a +20% increase.
What is Premier Biomedical market cap?▼
Today Premier Biomedical has the market capitalization of 779,988
What were Premier Biomedical earnings last quarter?▼
BIEI earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Premier Biomedical revenue for the last year?▼
Premier Biomedical revenue for the last year amounts to 0 USD.
What is Premier Biomedical net income for the last year?▼
BIEI net income for the last year is -198,000 USD.
How many employees does Premier Biomedical have?▼
As of April 24, 2026, the company has 4 employees.
In which sector is Premier Biomedical located?▼
Premier Biomedical operates in the Health & Wellness sector.
When did Premier Biomedical complete a stock split?▼
The last stock split for Premier Biomedical was on June 27, 2018 with a ratio of 1:250.
Where is Premier Biomedical headquartered?▼
Premier Biomedical is headquartered in Jackson Center, United States.